Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy

Pharmaceutical Development and Technology

Volumn 21, Issue 3, 2016, Pages 277-281

  Han, Yiqun ^a   Li, Ye ^b   Zhang, Peng ^a   Sun, Jiping ^a   Li, Xianzhen ^a   Sun, Xin ^a   Kong, Fansheng ^a  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

^b JINAN INFECTIOUS DISEASE HOSPITAL   (China)

Author keywords

Active targeting; gene therapy; nanostructured lipid carriers; transferrin modification

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; NANOCARRIER; TRANSFERRIN; DRUG CARRIER; GREEN FLUORESCENT PROTEIN; LIPID; NANOMATERIAL; NANOPARTICLE;

ADENOCARCINOMA CELL LINE; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GENE THERAPY; CONTROLLED STUDY; DRUG COATING; GENE DELIVERY SYSTEM; HUMAN; HUMAN CELL; IN VITRO GENE TRANSFER; IN VITRO STUDY; IN VIVO GENE TRANSFER; LUNG CANCER; MOUSE; NANOMEDICINE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE PROPERTY; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADMINISTRATION AND DOSAGE; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; GENE THERAPY; GENETIC TRANSFECTION; LUNG NEOPLASMS; PLASMID; PROCEDURES; TUMOR CELL LINE;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ANIMALS; CELL LINE, TUMOR; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GENETIC THERAPY; GREEN FLUORESCENT PROTEINS; HUMANS; LIPIDS; LUNG NEOPLASMS; MICE; NANOMEDICINE; NANOPARTICLES; NANOSTRUCTURES; PARTICLE SIZE; PLASMIDS; TRANSFECTION;

EID: 84956530133     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2014.996900     Document Type: Article

References (21)

1. Sundaram S, Trivedi R, Durairaj C, et al. Targeted drug and gene delivery systems for lung cancer therapy. Clin Cancer Res 2009; 15: 7299-7308
2. Siegel R, Ward E, Brawley O, Jamel A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212-236
3. Kawabata A, Baoum A, Ohta N, et al. Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth. Cancer Res 2012; 72: 2057-2067
4. Kong F, Ge L, Liu X, et al. Mannan-modified PLGA nanoparticles for targeted gene delivery. Int J Photoenergy 2011; 2012: 926754
5. Kong F, Zhou F, Ge L, et al. Mannosylated liposomes for targeted gene delivery. Int J Nanomedicine 2012; 7: 1079-1089
6. Jiang Z, Sun C, Yin Z, et al. Comparison of two kinds of nanomedicine for targeted gene therapy: premodified or postmodified gene delivery systems. Int J Nanomedicine 2012; 7: 2019-2031
7. Selvamuthukumar S, Velmurugan R. Nanostructured lipid carriers: a potential drug carrier for cancer chemotherapy. Lipids Health Dis 2012; 11: 159. doi: 10.1186/1476-511X-11-159
8. Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002; 54: S131-S155
9. Saupe A, Wissing SA, Lenk A, et al. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC)-structural investigations on two different carrier systems. Bio-Med Mater Eng 2005; 15: 393-402
10. Bellocq NC, Pun SH, Jensen GS, Davis ME. Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery. Bioconjug Chem 2003; 14: 1122-1132
11. Li H, Qian ZM. Transferrin/transferrin receptor-mediated drug delivery. Med Res Rev 2002; 22: 225-250
12. Maruyama K. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv Drug Deliv Rev 2011; 63: 161-169
13. Lukyanov AN, Gao Z, Mazzola L, Torchilin VP. Polyethylene glycoldiacyllipid micelles demonstrate increased accumulation in subcutaneous tumors in mice. Pharm Res 2002; 19: 1424-1429
14. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005; 4: 145-160
15. Torchilin VP. Multifunctional nanocarriers. Adv Drug Deliv Rev 2006; 58: 1532-1555
16. Wang W, Zhou F, Ge L, et al. Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection. Int J Nanomedicine 2012; 7: 2513-2522
17. Yu YH, Kim E, Park DE, et al. Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA. Eur J Pharm Biopharm 2012; 80: 268-273
18. Li P, Liu D, Miao L, et al. A pH-sensitive multifunctional gene carrier assembled via layer-by-layer technique for efficient gene delivery. Int J Nanomedicine 2012; 7: 925-939
19. Kamiya H, Akita H, Harashima H. Pharmacokinetic and pharmacodynamic considerations in gene therapy. Drug Discov Today 2003; 8: 990-996
20. Singh M. Transferrin as a targeting ligand for liposomes and anticancer drugs. Curr Pharm Des 1999; 5: 443-451
21. Yu W, Liu C, Liu Y, et al. Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages. Pharm Res 2010; 27: 1584-1596